Breakfast Symposia

Breakfast Symposia will be held on Wednesday 12 August. Breakfast will be available from 0730 outside each room.


Time:	0745-0845hrs
Topic:	Australian experience With Absorb – what have we learnt so far? Over 100,000 patients have been treated with Absorb since it became commercially available in 2012, in Europe. With TGA approval granted in September 2014, Australian experience is growing fast and we invite you to hear from a variety of Interventional Cardiologists to share their experience. This meeting will be largely case-based and will be chaired by Australia’s most experienced Absorb operators, Dr Nigel Jepson, Dr Ron Dick and Prof Carl Schultz.
Chairs:	Dr Nigel Jepson, Dr Ron Dick and Prof Carl Schultz
Room:	Meeting Room 213
Cost:	Complimentary, please indicate your attendance when completing your ASM registration.


Time:	0745-0845hrs (breakfast from 7.15am)
Topic 1:	Uncontrolled hypertension – is RDN the answer? 0745-0800hrs History of renal denervation & key confounders in the clinical dataset: procedure, drug variability and patient population. Prof Markus Schlaich 0800-0815hrs Anatomical optimisation for ablations and introduction to the SPYRAL-HTN Global Clinical Trial Program & the BakerIDI RDN trial Associate Prof Tony Walton
Topic 2:	CoreValve™ and Evolut R™ – a practical approach 0815-0845hrs This session will cover new data for the catheter based valve, Evolut R, and the practical considerations for selecting the appropriate patient for these two valve options Dr Sanjeevan Pasupati and Prof Martin Ng
Chairs:	Dr Jamie Rankin and Samantha Harrup
Room:	Meeting Room 220
Cost:	Complimentary, please indicate your attendance when completing your ASM registration.


Time:	0745-0845hrs
Topic:	TAVI in 2015 is mature and predictable and is now challenging the concept that surgical AVR is the gold standard in elderly patients. We are thrilled to have our newly appointed Vice President of Medical Affairs - Dr. Martyn Thomas MD, FRCP to present the latest clinical evidence and global perspectives on the application of TAVI in modern cardiovascular medicine. As the previous clinical director of cardiovascular services at St. Thomas’ Hospital in London since 2007, Martyn is highly regarded as a leader in interventional cardiology, and specifically in Transcatheter heart valve therapies, research and education. In addition to the lecture content, Martyn will facilitate local clinical case studies in an “Advanced Learning Environment” designed to address questions for experienced TAVI operators & teams managing challenging TAVI cases.
Chairs:	Dr Martyn Thomas, MD, FRCP, VP Medical Affairs, Edwards Lifesciences
Room:	Meeting Room 219
Cost:	Complimentary, please indicate your attendance when completing your ASM registration.